AAPM&R Partners with the American Medical Association on the “Share Your Story” Campaign to End the Opioid Epidemic
MIPS Status Must Be Checked Online
Ampicillin and Sulbactam for Injection USP, 3 g Single-Dose Vials by AuroMedics Pharma: Recall - Presence of Red Particulate Matter
Piperacillin and Tazobactam for Injection, USP 3.375 g Vials by AuroMedics Pharma: Recall - Vials Contain Particulate Matter
Look for Your May Issue of The Physiatrist
Live Course: Navigating the Opioid Crisis: Perils, Pitfalls and Practical Solutions
Join CMS for a Webinar on Participation Criteria for Year 2 of the Quality Payment Program
CMS Proposes Changes to IRF, SNF and Inpatient Prospective Payment Systems
Payer Denials: A Note from Annie Purcell, DO, FAAPMR
Lamictal (lamotrigine): Drug Safety Communication - Serious Immune System Reaction
AAPM&R Members in the News: April 2018
Academy Introduces Reimbursement Resources for Residents
April Coding Q&A
AAPM&R Signs on to AMA Letter Urging CMS to Reduce 2018 Reporting Period
Apply to Participate in the 2018 Center for Medicare & Medicaid Services (CMS) Study on Burdens Associated with Reporting Quality Measures to Receive Improvement Activity Credit for 2018
Coastal Meds to Recall All Products Marketed as Sterile
Sterile Injectable Products by Premier Pharmacy Labs: Recall - Lack of Sterility Assurance
Share Your Feedback About Continuing Board Certification by May 11
Look Up if You Need to Participate in MIPS in 2018
Academy Advocacy Win: Michigan BCBS Blue Care Network Will Continue to Cover Hyaluronic Acid Injections Until Further Notice